Open Access
The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards
Josephine Fox
1
,
Ashley Rumsey
1
,
Rebecca Rojek
1
,
Kathleen Rensing
1
,
Heather Gasama
1
,
Lydia Grimes-Jenkins
1
,
HELEN WOOD
1
,
Erik R. Dubberke
2
,
David J. Warren
2
1
Barnes-Jewish Hospital, St. Louis, Missouri, USA
|
Publication type: Journal Article
Publication date: 2023-03-01
scimago Q2
wos Q3
SJR: 0.572
CiteScore: 3.2
Impact factor: 1.9
ISSN: 25900889
PubMed ID:
36785770
Infectious Diseases
Public Health, Environmental and Occupational Health
Abstract
Prevention of hazardous drug exposure is essential in averting unnecessary health risks to health care workers (HCW). To address the risk to HCWs when handling hazardous drugs, engineering controls can be utilized to reduce the exposure. A closed system transfer device (CSTD) was introduced for hazardous drugs administration in 6 oncology wards; this new CSTD was associated with a significant increase in CLABSI rates.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Frontiers in Pharmacology
1 publication, 50%
|
|
|
AAPS Journal
1 publication, 50%
|
|
|
1
|
Publishers
|
1
|
|
|
Frontiers Media S.A.
1 publication, 50%
|
|
|
Springer Nature
1 publication, 50%
|
|
|
1
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2
Total citations:
2
Citations from 2024:
2
(100%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Fox J. et al. The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards // Infection Prevention in Practice. 2023. Vol. 5. No. 1. p. 100268.
GOST all authors (up to 50)
Copy
Fox J., Rumsey A., Rojek R., Rensing K., Gasama H., Grimes-Jenkins L., WOOD H., Dubberke E. R., Warren D. J. The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards // Infection Prevention in Practice. 2023. Vol. 5. No. 1. p. 100268.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.infpip.2023.100268
UR - https://doi.org/10.1016/j.infpip.2023.100268
TI - The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards
T2 - Infection Prevention in Practice
AU - Fox, Josephine
AU - Rumsey, Ashley
AU - Rojek, Rebecca
AU - Rensing, Kathleen
AU - Gasama, Heather
AU - Grimes-Jenkins, Lydia
AU - WOOD, HELEN
AU - Dubberke, Erik R.
AU - Warren, David J.
PY - 2023
DA - 2023/03/01
PB - Elsevier
SP - 100268
IS - 1
VL - 5
PMID - 36785770
SN - 2590-0889
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2023_Fox,
author = {Josephine Fox and Ashley Rumsey and Rebecca Rojek and Kathleen Rensing and Heather Gasama and Lydia Grimes-Jenkins and HELEN WOOD and Erik R. Dubberke and David J. Warren},
title = {The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards},
journal = {Infection Prevention in Practice},
year = {2023},
volume = {5},
publisher = {Elsevier},
month = {mar},
url = {https://doi.org/10.1016/j.infpip.2023.100268},
number = {1},
pages = {100268},
doi = {10.1016/j.infpip.2023.100268}
}
Cite this
MLA
Copy
Fox, Josephine, et al. “The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards.” Infection Prevention in Practice, vol. 5, no. 1, Mar. 2023, p. 100268. https://doi.org/10.1016/j.infpip.2023.100268.